Literature DB >> 1546192

Prognostic factors in nasopharyngeal carcinoma investigated by computer tomography--an analysis of 659 patients.

P Teo1, W Shiu, S F Leung, W Y Lee.   

Abstract

A total of 659 freshly diagnosed nasopharyngeal carcinoma (NPC) (1984-1987), were investigated by computed tomography (CT), treated with locoregional radiotherapy to radical dose, and given neoadjuvant chemotherapy (CHEMO) with 2-3 courses of cisplatinum and 5-fluorouracil for bulky (greater than or equal to 4 cm) cervical nodal metastasis and booster radiotherapy (PPB) for parapharyngeal disease. All except 15 patients were fully evaluable with complete data entry till death or to the last follow-up (minimum 2 years). The data have been analysed extensively to identify variables of potential prognostic significance. The assessed factors include patients' sex and age, nasal involvement (NAS), oropharyngeal involvement (ORO), parapharyngeal involvement (PAR), muscle involvement (MU), skull base involvement (BS), cranial nerves (II-VIII) palsy (CN1), cranial nerves (IX-XII) palsy (CN2), intracranial extension (IC), laryngopharyngeal extension (HYP), confinement to nasopharynx (NP), Ho's N-stage (Nho), maximal nodal size (Nmax), nodal mobility (Nf- fixed, Npf- doubt in mobility, Nm- mobile), nodal laterality (unilateral, contralateral, bilateral), nodal multiplicity (single, multiple), and presentation with distant metastasis (M1). These factors have been assessed as to their interdependence and correlation with the clinical course (study endpoints) using both monovariate analyses and Cox's Regression model. Significant association among Ho's T2 and T3 features was identified. Advanced Ho's N-stage correlated significantly with bulky nodes, multiple nodes, fixed nodes, and, contralateral and bilateral nodes. Poor prognostic factors found to be significant by both monovariate analyses and Cox's Regression model included the M1, Nho (advanced), CN1, BS, and CN2 for the actuarial survival (ASR) for all patients (659), the Nho (advanced), CN1, CN2, and BS for the ASR for the non-metastatic patients (628), the absence of NP and the male sex for the local failure rate (628), the Nho (advanced), CN2, and BS for the distant metastasis rate (628), and the Nho (advanced), CN1, and BS for the disease-free survival (DFS) (628). In addition, old age, male sex, and the presence of parapharyngeal disease were probably significant in predicting poor survival (ASR); CN1 was probably significant in predicting more local failures, and, the parapharyngeal disease and the intracranial extension for more distant metastases. The Ho's N-staging is superior to the other N-stage classifications, because once the Ho's N-stage has been determined, other nodal characteristics including nodal size, multiplicity, laterality, and fixity, are prognostically insignificant.

Entities:  

Mesh:

Year:  1992        PMID: 1546192     DOI: 10.1016/0167-8140(92)90339-v

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  8 in total

1.  Magnetic resonance imaging staging of nasopharyngeal carcinoma in the head and neck.

Authors:  Ann Dorothy King; Kunwar Suryaveer Singh Bhatia
Journal:  World J Radiol       Date:  2010-05-28

2.  EphA2 silencing in nasopharyngeal carcinoma leads to decreased proliferation, invasion and increased sensitization to paclitaxel.

Authors:  Pingqing Tan; Yong Liu; Changyun Yu; Zhongwu Su; Guo Li; Xiaojuan Zhou; Donghai Huang; Xin Zhang; Yuanzheng Qiu; Yongquan Tian
Journal:  Oncol Lett       Date:  2012-06-08       Impact factor: 2.967

3.  A comparative study of technetium-99m sestamibi and technetium-99m tetrofosmin single-photon tomography in the detection of nasopharyngeal carcinoma.

Authors:  L Kostakoglu; U Uysal; E Ozyar; F B Demirkazik; M Hayran; L Atahan; C F Bekdik
Journal:  Eur J Nucl Med       Date:  1997-06

4.  Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes?

Authors:  Tzu-Chen Yen; Yu-Chen Chang; Sheng-Chieh Chan; Joseph Tung-Chieh Chang; Ching-Han Hsu; Kun-Ju Lin; Wuu-Jyh Lin; Ying-Kai Fu; Shu-Hang Ng
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12-30       Impact factor: 9.236

Review 5.  Contribution of radiotherapy to function preservation and cancer outcome in primary treatment of nasopharyngeal carcinoma.

Authors:  Anne W M Lee
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

6.  3D-CT implanted interstitial brachytherapy for T2b nasopharyngeal carcinoma.

Authors:  Yu-Feng Ren; Yuan-Hong Gao; Xin-Ping Cao; Wei-Jun Ye; Bin S Teh
Journal:  Radiat Oncol       Date:  2010-11-23       Impact factor: 3.481

7.  A novel N staging system for NPC based on IMRT and RTOG guidelines for lymph node levels: Results of a prospective multicentric clinical study.

Authors:  Min Kang; Pingting Zhou; Tingting Wei; Tingting Zhao; Jianxiong Long; Guisheng Li; Haolin Yan; Guosheng Feng; Meilian Liu; Jinxian Zhu; Rensheng Wang
Journal:  Oncol Lett       Date:  2018-05-09       Impact factor: 2.967

8.  Maximal lymph nodal diameter on N stage of nasopharyngeal carcinoma.

Authors:  Shi-Ting Huang; Song Qu; Ling Li; Kai-Hua Chen; Xiao-Dong Zhu; Xin-Bin Pan
Journal:  Medicine (Baltimore)       Date:  2021-07-02       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.